Summary<\/span><\/p>Finding better therapies for the treatment of brain tumors is hampered by the lack of consistently obtained molecular data in a large sample set and the ability to integrate biomedical data from disparate sources enabling translation of therapies from bench to bedside. Hence, a critical factor in the advancement of biomedical research and clinical translation is the ease with which data can be integrated, redistributed, and analyzed both within and across functional domains. Novel biomedical informatics infrastructure and tools are essential for developing individualized patient treatment based on the specific genomic signatures in each patient's tumor. The Repository of Molecular Brain Neoplasia Data (REMBRANDT) is aimed at facilitating discovery by connecting the dots between clinical information and genomic characterization data. REMBRANDT contains data generated through the Glioma Molecular Diagnostic Initiative from 874 glioma specimens comprising approximately 566 gene expression arrays, 834 copy number arrays, and 13,472 clinical phenotype data points. These data are currently housed in Georgetown University's G-DOC System<\/a> <\/u> and are described in a related manuscript<\/a> <\/u>. \u00a0<\/span>This image collection was created as a companion data set to augment the larger\u00a0REMBRANDT\u00a0project. It contains the pre-surgical magnetic resonance (MR) multi-sequence images from 130 REMBRANDT patients.\u00a0<\/p>